This Is What Whales Are Betting On Merck & Co
This Is What Whales Are Betting On Merck & Co
In today's trading context, the average open interest for options of Merck & Co stands at 2075.86, with a total volume reaching 6,696.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Merck & Co, situated within the strike price corridor from $100.0 to $120.0, throughout the last 30 days.Financial giants have made a conspicuous bullish move on Merck & Co. Our analysis of options history for Merck & Co (NYSE:MRK) revealed 9 unusual trades.
金融巨頭在默沙東股份上做出了明顯的看好動作。我們對紐交所默沙東（NYSE:MRK）的期權歷史進行分析發現了9筆飛凡交易。
Delving into the details, we found 55% of traders were bullish, while 33% showed bearish tendencies. Out of all the trades we spotted, 4 were puts, with a value of $119,340, and 5 were calls, valued at $224,086.
深入細節，我們發現55%的交易員持有看好看跌，而33%顯示了看淡傾向。在我們觀察到的所有交易中，有4筆看跌，價值爲$119,340，有5筆看漲，價值爲$224,086。
Projected Price Targets
預計價格目標
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $100.0 to $120.0 for Merck & Co over the last 3 months.
考慮到這些合同的成交量和未平倉合約量，似乎鯨魚們在過去3個月內一直將目標價區間鎖定在$100.0至$120.0之間。
Volume & Open Interest Trends
成交量和未平倉量趨勢
In today's trading context, the average open interest for options of Merck & Co stands at 2075.86, with a total volume reaching 6,696.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Merck & Co, situated within the strike price corridor from $100.0 to $120.0, throughout the last 30 days.
在當天的交易環境中，默沙東（Merck & Co）期權的平均未平倉合約量爲2075.86，總成交量達到6,696.00。附圖描繪了過去30天內默沙東高價值交易的看漲和看跌期權成交量和未平倉合約量的發展情況，這些交易位於$100.0至$120.0的執行價格走廊內。
Merck & Co Option Volume And Open Interest Over Last 30 Days
默克公司期權成交量和持倉量過去30天的情況
Largest Options Trades Observed:
觀察到的最大期權交易：
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MRK | CALL | TRADE | BEARISH | 12/19/25 | $10.0 | $9.85 | $9.85 | $120.00 | $58.1K | 1.2K | 60 |
| MRK | CALL | TRADE | NEUTRAL | 01/16/26 | $24.5 | $20.0 | $21.9 | $100.00 | $56.9K | 318 | 26 |
| MRK | CALL | SWEEP | BEARISH | 10/18/24 | $0.99 | $0.95 | $0.95 | $118.00 | $44.4K | 972 | 1.6K |
| MRK | CALL | SWEEP | BULLISH | 10/18/24 | $0.9 | $0.88 | $0.9 | $118.00 | $36.9K | 972 | 2.8K |
| MRK | PUT | TRADE | BEARISH | 10/18/24 | $3.35 | $3.2 | $3.35 | $118.00 | $34.8K | 16 | 0 |
| 標的 | 看跌/看漲 | 交易類型 | 情緒 | 到期日 | 賣盤 | 買盤 | 價格 | 執行價格 | 總交易價格 | 未平倉合約數量 | 成交量 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MRK | 看漲 | 交易 | 看淡 | 2025年12月19日 | $10.0 | $9.85 | $9.85 | $120.00 | $58.1K | 1.2K | 60 |
| MRK | 看漲 | 交易 | 中立 | 01/16/26 | $24.5 | $20.0 | $21.9 | $100.00。 | $56.9K | 318 | 26 |
| MRK | 看漲 | SWEEP | 看淡 | 10/18/24 | $0.99 | 0.95美元 | 0.95美元 | $118.00 | $44.4千美元 | 972 | 1.6K |
| MRK | 看漲 | SWEEP | 看好 | 10/18/24 | $0.9 | $0.88 | $0.9 | $118.00 | $36.9K | 972 | 2.8K |
| MRK | 看跌 | 交易 | 看淡 | 10/18/24 | $3.35 | $3.2 | $3.35 | $118.00 | $34.8K | 16 | 0 |
About Merck & Co
關於默沙東
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
默沙東生產多種藥品，治療多種領域的疾病，包括心代謝症、癌症和感染。在癌症領域，該公司的免疫腫瘤學平台正在成爲總銷售額的主要貢獻者。該公司還具有實質性的疫苗業務，包括預防兒童疾病以及人類乳頭瘤病毒（HPV）治療。此外，默沙東出售與動物健康相關的藥品。從地理角度來看，公司銷售額的近一半來自於美國境內。
After a thorough review of the options trading surrounding Merck & Co, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
對於默沙東周圍的期權交易進行全面審查後，我們開始更詳細地審查該公司的情況。這包括對其當前市場地位和表現的評估。
Where Is Merck & Co Standing Right Now?
默克與有限公司當前的處境如何？
- With a volume of 7,899,351, the price of MRK is down -0.1% at $114.84.
- RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.
- Next earnings are expected to be released in 36 days.
- 成交量爲7,899,351，默沙東的價格下跌-0.1%，報114.84美元。
- RSI指標暗示該標的股票目前處於超買和超賣的中立區間。
- 預計下一輪收益發布還有36天。
What Analysts Are Saying About Merck & Co
關於默沙東的分析師觀點
2 market experts have recently issued ratings for this stock, with a consensus target price of $155.0.
最近有2位市場專家對這支股票發表了評級，一致目標價爲155.0美元。
Unusual Options Activity Detected: Smart Money on the Move
檢測到期權異動：智慧資金在行動。
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. Click here for access.* An analyst from Cantor Fitzgerald downgraded its action to Overweight with a price target of $155. * An analyst from Cantor Fitzgerald has revised its rating downward to Overweight, adjusting the price target to $155.
飛凡期權板塊提前發現潛在的市場活躍個股。查看大額資金對您最喜歡的股票的持倉。單擊此處訪問。* Cantor Fitzgerald的分析師調降其評級至超重，目標價爲155美元。* Cantor Fitzgerald的分析師將評級調降至超重，調整目標價至155美元。
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Merck & Co options trades with real-time alerts from Benzinga Pro.
期權交易存在更高的風險和潛在回報。機智的交易者通過不斷學習、調整他們的策略、監測多個因子和密切關注市場動向來控制這些風險。通過Benzinga Pro實時提醒了解最新的默沙東期權交易。
譯文內容由第三人軟體翻譯。